<DOC>
	<DOCNO>NCT00597376</DOCNO>
	<brief_summary>The purpose six-month research study determine Cerefolin NAC reduce level substance blood may associate think ability health brain cell subject memory concern compare standard multivitamin . Cerefolin NAC available dietary supplement via prescription physician . The multivitamin use study contains Recommended Daily Intake recommend old person .</brief_summary>
	<brief_title>Study Effects Cerefolin NAC Inflammation Blood Markers Older Individuals With Memory Complaints</brief_title>
	<detailed_description>Study Phase : Exploratory Indication : Memory Complaints Study Design : A single-center , double-blind , placebo-controlled study 100 subject memory complaint follow 6 month ( 4 visit ) use Cerefolin® NAC placebo day addition standardize multivitamin . Sample Size : 100 subject follow : 1 . 50 Cerefolin® NAC + multivitamin ; , 2 . 50 Placebo + multivitamin . Primary Objective : To determine Cerefolin® NAC ( compare multivitamin ) decrease blood level homocysteine , increase blood level glutathione ( marker oxidative stress ) , increase ratio Aβ42 Aβ40 ( marker beta-amyloid ) may relate neuronal injury inflammation . Secondary Objectives : 1 . To determine Cerefolin® NAC reduce hs-CRP TNF-α blood level , increase IL-6 blood level . 2 . To determine Cerefolin® NAC ( compare Placebo ) reduce plasma F2 isoprostane increase potential antioxidant ( PAO ) level . 3 . To assess tolerability Cerefolin® NAC 4 . To explore effect Cerefolin® NAC 6-month change : ( ) global specific cognitive domain standardize neuropsychological test battery , ( b ) quality life measure SF-36 , ( c ) instrumental basic activity daily live , ( ) MADRS ; ( e ) performance-based physical function . 5 . To explore change homocysteine level related change plasma glutathione , hs-CRP , IL-6 , TNF-α , F2-isoprostane , PAO level change ratio Aβ42 Aβ40 . 6 . To explore effect MS AG2756 , APOE MFTHR relationship examine Secondary Objective # 5 . 7 . To explore relationship B12 status status cognition NOTE : For individual successfully complete 6-month blinded phase , 12-month open-label extension Cerefolin NAC + multivitamin . The primary purpose exploratory , open-label extension phase CERE-001 study systematically collect long-term safety data CEREFOLIN NAC usage additional 12-month period .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Memory Disorders</mesh_term>
	<mesh_term>Amnesia</mesh_term>
	<criteria>Age great 60 ; Memory complaint define two question : 1 . `` Do The subject think memory problem ? `` ; , 2 . `` Has decline memory last 10 year ? '' Fluency English ; Ability ingest oral medication ; , Willing replace current vitamin intake standardized multivitamin provide study . Clinical stroke Parkinson 's disease ; Taking FDA approve drug symptomatic treatment Alzheimer 's disease ( Aricept , Razadyne , Exelon , and/or Namenda ) ; History significant renal insufficiency ( creatinine ≥1.5 ) ; History renal stone peptic ulcer disease ; Use vitamin supplement contain 400mcg folic acid per day within 2 month Screen Visit ; As determine study physician , clinically significant serum folate vitamin B12 deficiency screen blood test would require clinical evaluation treatment As determine study physician , clinically significant medical condition , physical exam finding abnormal blood test screen would require clinical evaluation treatment B12 injection 6 month prior Screen Visit ; Confirmed clinical diagnosis Mild Cognitive Impairment ( MCI ) , vascular dementia Alzheimer 's Disease ( AD ) ; , Known hypersensitivity Lmethylfolate , methylcobalamin Nacetylcysteine . Use investigational agent use 30 day prior Screening .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>memory loss</keyword>
</DOC>